Skip to content

ALEXION PHARMACEUTICALS, INC.

Delisted

CIK 899866fmd_0EJCHRGVB7FMQ685FSEV3PVNK1Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2008 to Mar 31, 2021, 49 periods

Latest annual · FY2020

Millions
Total revenues
6,070
Gross profit
5,516
Operating income
632
Net income
603
Free cash flow
2,896

Latest quarter · Q1 FY2021

Millions
Total revenues
1,637
Gross profit
1,511
Operating income
636
Net income
636
Free cash flow
617
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2017 to FY2020
+19.6%
Revenue, 5 yearsFY2015 to FY2020
+18.5%
Net income, 5 yearsFY2015 to FY2020
+33.1%

ALEXION PHARMACEUTICALS, INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2020FY2019ChangeSource
Revenue$6.1 billion$5 billion+21.6%10-K 2021-02-08 · proof
Gross profit$5.5 billion$4.6 billion+20%10-K 2021-02-08 · proof
Operating income$632.3 million$2.1 billion-70.2%10-K 2021-02-08 · proof
Net income$603.4 million$2.4 billion-74.9%10-K 2021-02-08 · proof
Cash from operating activities$3 billion$2.1 billion+44%10-K 2021-02-08 · proof
Free cash flow$2.9 billion$1.9 billion+50%10-K 2021-02-08 · proof
Total assets$18.1 billion$17.5 billion+3.2%10-K 2021-02-08 · proof
Total liabilities$6.5 billion$6.3 billion+2.9%10-K 2021-02-08 · proof
Cash and cash equivalents$3 billion$2.7 billion+10.4%10-K 2021-02-08 · proof
Total debt$2.6 billion$2.5 billion+2.4%10-K 2021-02-08 · proof
What was ALEXION PHARMACEUTICALS, INC.'s revenue in fiscal 2020?
ALEXION PHARMACEUTICALS, INC. reported revenue of $6.1 billion for fiscal 2020 (the year ended Dec 31, 2020), against $5 billion the year before (+21.6%). Source: the 10-K filed with the SEC on Feb 8, 2021. SEC
What was ALEXION PHARMACEUTICALS, INC.'s gross profit in fiscal 2020?
ALEXION PHARMACEUTICALS, INC. reported gross profit of $5.5 billion for fiscal 2020 (the year ended Dec 31, 2020), against $4.6 billion the year before (+20%). Source: the 10-K filed with the SEC on Feb 8, 2021. SEC
What was ALEXION PHARMACEUTICALS, INC.'s operating income in fiscal 2020?
ALEXION PHARMACEUTICALS, INC. reported operating income of $632.3 million for fiscal 2020 (the year ended Dec 31, 2020), against $2.1 billion the year before (-70.2%). Source: the 10-K filed with the SEC on Feb 8, 2021. SEC
What was ALEXION PHARMACEUTICALS, INC.'s net income in fiscal 2020?
ALEXION PHARMACEUTICALS, INC. reported net income of $603.4 million for fiscal 2020 (the year ended Dec 31, 2020), against $2.4 billion the year before (-74.9%). Source: the 10-K filed with the SEC on Feb 8, 2021. SEC
What was ALEXION PHARMACEUTICALS, INC.'s cash from operating activities in fiscal 2020?
ALEXION PHARMACEUTICALS, INC. reported cash from operating activities of $3 billion for fiscal 2020 (the year ended Dec 31, 2020), against $2.1 billion the year before (+44%). Source: the 10-K filed with the SEC on Feb 8, 2021. SEC
What was ALEXION PHARMACEUTICALS, INC.'s free cash flow in fiscal 2020?
ALEXION PHARMACEUTICALS, INC. reported free cash flow of $2.9 billion for fiscal 2020 (the year ended Dec 31, 2020), against $1.9 billion the year before (+50%). Source: the 10-K filed with the SEC on Feb 8, 2021. SEC
What are ALEXION PHARMACEUTICALS, INC.'s total assets?
As of Dec 31, 2020, ALEXION PHARMACEUTICALS, INC. reported total assets of $18.1 billion, against $17.5 billion a year earlier (+3.2%). Source: the 10-K filed with the SEC on Feb 8, 2021. SEC
What are ALEXION PHARMACEUTICALS, INC.'s total liabilities?
As of Dec 31, 2020, ALEXION PHARMACEUTICALS, INC. reported total liabilities of $6.5 billion, against $6.3 billion a year earlier (+2.9%). Source: the 10-K filed with the SEC on Feb 8, 2021. SEC
What are ALEXION PHARMACEUTICALS, INC.'s cash and cash equivalents?
As of Dec 31, 2020, ALEXION PHARMACEUTICALS, INC. reported cash and cash equivalents of $3 billion, against $2.7 billion a year earlier (+10.4%). Source: the 10-K filed with the SEC on Feb 8, 2021. SEC
What is ALEXION PHARMACEUTICALS, INC.'s total debt?
As of Dec 31, 2020, ALEXION PHARMACEUTICALS, INC. reported total debt of $2.6 billion, against $2.5 billion a year earlier (+2.4%). Source: the 10-K filed with the SEC on Feb 8, 2021. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:899866&period_type=annual&limit=5"

Information only, not investment advice.